Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Left ventricular remodeling and dysfunction in primary aldosteronism
Cheng‐Hsuan Tsai, Chien‐Ting Pan, Yi‐Yao Chang, et al.
Journal of Human Hypertension (2020) Vol. 35, Iss. 2, pp. 131-147
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Aldosterone as a Mediator of Cardiovascular Damage
Fabrizio Buffolo, Martina Tetti, Paolo Mulatero, et al.
Hypertension (2022) Vol. 79, Iss. 9, pp. 1899-1911
Open Access | Times Cited: 103
Primary Aldosteronism: State-of-the-Art Review
Anand Vaidya, Gregory L. Hundemer, Kazutaka Nanba, et al.
American Journal of Hypertension (2022) Vol. 35, Iss. 12, pp. 967-988
Open Access | Times Cited: 64
Non-Hypertensive Effects of Aldosterone
Natalia Ekman, Ashley Grossman, Anna Nieckarz, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 540-540
Open Access | Times Cited: 1
The Effect of Aldosterone on Cardiorenal and Metabolic Systems
Hiromasa Otsuka, Masanori Abe, Hiroki Kobayashi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5370-5370
Open Access | Times Cited: 21
Recent progress in unraveling cardiovascular complications associated with primary aldosteronism: a succinct review
Wei‐Ting Wang, Tsung-Hui Wu, Leay‐Kiaw Er, et al.
Hypertension Research (2024) Vol. 47, Iss. 5, pp. 1103-1119
Closed Access | Times Cited: 6
Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities Study
Jenifer M. Brown, Magnus Wijkman, Brian Claggett, et al.
Hypertension (2022) Vol. 79, Iss. 9, pp. 1984-1993
Open Access | Times Cited: 26
Aldosterone and aldosterone synthase inhibitors in cardiorenal disease
Subodh Verma, Avinash Pandey, Arjun Pandey, et al.
AJP Heart and Circulatory Physiology (2023) Vol. 326, Iss. 3, pp. H670-H688
Closed Access | Times Cited: 12
Artificial intelligence in assessing cardiovascular diseases and risk factors via retinal fundus images: A review of the last decade
Mirsaeed Abdollahi, Ali Jafarizadeh, Amirhosein Ghafouri Asbagh, et al.
Wiley Interdisciplinary Reviews Data Mining and Knowledge Discovery (2024) Vol. 14, Iss. 6
Open Access | Times Cited: 4
Nationwide, Pragmatic, Direct-to-Patient Primary Aldosteronism Testing Program
Jenifer M. Brown, Laura C Tsai, E Abel, et al.
Hypertension (2025)
Closed Access
Autonomous cortisol secretion is associated with worse arterial stiffness and vascular fibrosis in primary aldosteronism: a cross-sectional study with follow-up data
Cheng‐Hsuan Tsai, Che‐Wei Liao, Xue-Ming Wu, et al.
European Journal of Endocrinology (2022) Vol. 187, Iss. 1, pp. 197-208
Closed Access | Times Cited: 18
Cardiovascular and metabolic characters of KCNJ5 somatic mutations in primary aldosteronism
Yi‐Yao Chang, Bo‐Ching Lee, Zheng‐Wei Chen, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 8
Adrenal Ablation Versus Mineralocorticoid Receptor Antagonism for the Treatment of Primary Aldosteronism: A Single-Center Prospective Cohort Study
Yaqiong Zhou, Qiting Liu, Xinquan Wang, et al.
American Journal of Hypertension (2022) Vol. 35, Iss. 12, pp. 1014-1023
Open Access | Times Cited: 13
Management of the ‘wicked’ combination of heart failure and chronic kidney disease in the patient with diabetes
David S.H. Bell, Janet B. McGill, Terri Jerkins
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 10, pp. 2795-2804
Open Access | Times Cited: 7
Bilateral adrenal artery embolization for the treatment of idiopathic hyperaldosteronism: A proof-of-principle single center study
Guo Ji, Changqiang Yang, Jixin Hou, et al.
Hypertension Research (2024) Vol. 48, Iss. 1, pp. 200-211
Closed Access | Times Cited: 2
Treatment of Primary Aldosteronism and Reversal of Renin Suppression Improves Left Ventricular Systolic Function
Troy Puar, Chin Kai Cheong, Roger Foo, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 12
Atrial Fibrillation and Aortic Ectasia as Complications of Primary Aldosteronism: Focus on Pathophysiological Aspects
Martina Bollati, Chiara Lopez, Fabio Bioletto, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2111-2111
Open Access | Times Cited: 10
New-Onset Atrial Fibrillation in Patients With Primary Aldosteronism Receiving Different Treatment Strategies: Systematic Review and Pooled Analysis of Three Studies
Cheng‐Hsuan Tsai, Yali Chen, Chien‐Ting Pan, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 14
Case report: Percutaneous adrenal arterial embolization cures resistant hypertension
Yaqiong Zhou, Dan Wang, Qiting Liu, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 9
Implication of MR Activity in Posttreatment Arterial Stiffness Reversal in Patients With Primary Aldosteronism
Zheng‐Wei Chen, Chien‐Ting Pan, Che‐Wei Liao, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 108, Iss. 3, pp. 624-632
Open Access | Times Cited: 9
Cardiovascular Disease in Obstructive Sleep Apnea: Putative Contributions of Mineralocorticoid Receptors
Mohammad Badran, Shawn B. Bender, David Gozal
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2245-2245
Open Access | Times Cited: 5
Diabetes mellitus is associated with worse baseline and less post-treatment recovery of arterial stiffness in patients with primary aldosteronism
Cheng‐Hsuan Tsai, Xue-Ming Wu, Che‐Wei Liao, et al.
Therapeutic Advances in Chronic Disease (2022) Vol. 13
Open Access | Times Cited: 8
Differences in Glycemic Abnormalities Between Primary Aldosteronism and Essential Hypertension: A Systematic Review and Meta-Analysis
Worapaka Manosroi, Pichitchai Atthakomol, Pittaporn Wattanawitawas, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 8
Diabetes mellitus is associated with more adverse non-hemodynamic left ventricular remodeling and less recovery in patients with primary aldosteronism
Uei-Lin Chen, Che‐Wei Liao, Shuo‐Meng Wang, et al.
Journal of Investigative Medicine (2023) Vol. 71, Iss. 2, pp. 101-112
Closed Access | Times Cited: 4
Myosin Light Chain Phosphatase Plays an Important Role in Cardiac Fibrosis in a Model of Mineralocorticoid Receptor‐Associated Hypertension
Zhe Ye, Ryuji Okamoto, Hiromasa Ito, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 5
Open Access | Times Cited: 1
Prevention and treatment of hypertensive left ventricular hypertrophy
Manvita Tatavarthy, John Stathopoulos, Ahmet Oktay
Current Opinion in Cardiology (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top